Not So Golden Handcuffs

By: Bella Hood

Wunderkind Sam Bankman-Fried, otherwise known as “SBF”, was sentenced to 25 years in prison and ordered to pay $11 billion on March 28, 2024. A federal court convicted SBF in November on seven counts of fraud, conspiracy, money laundering, and conspiracy to commit commodities and securities fraud.

The former 32-year-old billionaire is the son of two Stanford law professors. After graduating from the Massachusetts Institute of Technology, he worked at Jane Street Capital, a quantitative trading firm. FTX, an abbreviation of “Futures Exchange” was founded by SBF in 2018 as a centralized cryptocurrency exchange supporting futures for all major cryptocurrencies. At his height, SBF’s net worth was said to be around $26 billion. For reference, Beyonce’s is roughly $800 million. SBF also founded his own hedge fund, Alameda Research, which would go on to be a key player in his scheme to defraud investors.

In November 2022, FTX filed for Chapter 11 bankruptcy (handled by Sullivan & Cromwell) which requires the reorganization of the company’s assets and liabilities but does not kill the company outright. Even so, FTX is dead for all intents and purposes and announced in January it would not reopen its exchange and would liquidate all assets.

A New York jury found SBF guilty of all seven criminal counts, including wire fraud and conspiracy to commit wire fraud against FTX customers. Against Alameda Research lenders the court found SBF guilty of conspiracy to commit securities fraud, conspiracy to commit commodities fraud against FTX investors, and conspiracy to commit money laundering.

Congress enacted the wire fraud statute in 1952 as an extension of the 1872 mail fraud statute. In 1987, the Supreme Court broadly held in McNally v. United States that the statute applied to any act “designed to defraud by representations as to the past or present, or suggestions and promises as to the future.” Securities fraud refers to illegal activities that involve the deception of investors or the manipulation of financial markets. The Securities and Exchange Commission is the primary securities regulator in the U.S.

Commodities fraud is the sale or purported sale of a commodity through illegal means and often goes hand in hand with securities fraud. Since 2019, the Fraud Section of the Criminal Division of the U.S. Department of Justice has entered six corporate resolutions relating to violations of the commodities laws with a combined total monetary amount of over $1 billion. Money laundering is the act of disguising financial assets so they can be used without detection of the illegal activity that produced them.

Bernie Madoff, orchestrator of the biggest Ponzi scheme in history, was convicted of 11 federal felony counts, including securities fraud, wire fraud, mail fraud, and money laundering, which earned him a sentence of 150 years in prison.  His net assets in 2009 prior to sentencing totaled at least $823 million. It is estimated that he stole as much as $65 billion. In comparison, SBF was found to have cheated customers and investors of at least $10 billion. Jeffrey Skilling, the failed CEO of Enron at the time of its implosion, was convicted of an impressive 19 crimes, including 12 counts of securities fraud. Skilling was ultimately sentenced to 14 years in prison and ordered to pay $42 million in restitution to victims of the fraud. The energy and commodities trading holding company held $63.4 billion in assets before its stocks tanked.

Though a long line of financial fraudsters paved the way for SBF, the use of cryptocurrency to achieve such scale was largely unheard of. Bitcoin was the first cryptocurrency created and is younger than SBF himself, having launched in 2009. The public should expect to see the federal government go after an increasing number of crypto king copycats in the future in an attempt to strengthen guardrails on the industry.

In September of 2023, a cofounder of OneCoin, a now defunct cryptocurrency exchange, was sentenced to 20 years in prison for creating and promoting a phony cryptocurrency. Just this past month, OneCoin’s former head of legal and compliance, Irina Dilkinska was sentenced to four years in prison and ordered to forfeit over $111 million. Dilkinska pled guilty in November of 2023 to one count of conspiracy to commit wire fraud and one count of conspiracy to commit money laundering. March of 2024 was a busy month for the U.S. government because a jury also found the founder of Terraform Labs, a Singapore-based blockchain protocol and payment platform, liable for defrauding investors in 2021. Binance is yet another example of a cryptocurrency exchange riddled with fraud. In November of 2023 (sensing a trend?), the company and founder pleaded guilty to money laundering and other crimes, costing the company over $4 billion.

Treasury Secretary Janet Yellen set the tone when she told the industry: “Let me be clear, we’re also sending a message to the virtual currency industry more broadly – today and for the future, the virtual currency exchanges and financial technology firms wish to realize the tremendous benefits of being part of the US financial system they must play by the rules. If they do not, the US government will take action.” SBF’s sentence serves as a harbinger of the U.S. government’s approach to cryptocurrency fraud and the harsh punishments to come.

The Legal Battle Behind an Olympic Figure Skating Doping Controversy May Change Anti-Doping Rules

By: Bethany Butler

2022 Olympic Women’s Singles Figure Skating Doping Controversy 

The 2022 Winter Olympics in Beijing were overshadowed by an intense doping scandal in the women’s singles figure skating event. In February 2022, Kamila Valieva, a 15-year-old Russian figure skater (competing under the ROC “Russian Olympic Committee” due to Russia’s previous doping issues), participated in the Olympic figure skating team event. With the help of Valieva’s top scores, the ROC placed first in this event, followed by the United States in second, Japan in third, and Canada in fourth. At the time, the medal ceremony was delayed for this competition. It was later revealed that the results of Valieva’s drug test from the Russian championship a few months prior in December 2021 was the reason behind the delay. Valieva’s sample from the December 2021 competition was found to contain detectable amounts of trimetazidine (“TMZ”), which is a World Anti-Doping Agency banned substance that is thought to help with endurance and recovery. The timing and reporting of this doping violation was unfortunate as it led to issues regarding the results of the team event, and questions of whether Valieva would be allowed to compete in the individual competition. Quickly after the drug testing results came out, the Court of Arbitration for Sport decided that Valieva was ultimately allowed to compete in the individual event in part due to her protected status as a minor and the “untimely notification” of the anti-doping results. In the individual competition Valieva placed fourth while her Russian teammates, Anna Scherbakova and Sasha Trusova, earned the gold and silver medals respectively. Following the Olympics, the main unanswered question was whether Valieva’s scores would be disqualified, and if so, what would happen to the team event standings. 

Legal Battle and Ruling

The legal and procedural landscape surrounding Olympic sports and anti-doping policies involve the International Olympic Committee (“IOC”), the World Anti-Doping Agency (“WADA”) and the Court of Arbitration for Sport (“CAS”). WADA is a foundation initiated by the IOC and coordinates anti-doping efforts across nations. CAS is a mediator in anti-doping cases which handles WADA appeals “under the jurisdiction of World Anti-Doping Code signatories (Code).” In addition, CAS “provides for services to facilitate the settlement of sport-related disputes” and eventually handled the case between Valieva, the Russian Anti-Doping Agency (“RUSADA”), the International Skating Union (“ISU”), and WADA. 

Following delays from the RUSADA investigation into the Valieva case, WADA put the agency on notice that they will appeal the case to CAS if a resolution is not released. Eventually, RUSADA, the ISU, and WADA all appealed the case to CAS which resulted in closed hearings at CAS’s headquarters in Lausanne, Switzerland.  

In January of 2024, almost two years after the 2022 Winter Olympic Games, CAS ruled that Valieva was guilty of an anti-doping violation for her positive TMZ sample. The ruling resulted in a four year ban, retroactive to December 25, 2021, the date of Valieva’s positive test at the 2021 Russian Championship. Valieva’s Olympic results were subsequently disqualified due to this ban, which led many to speculate how the IOC would handle the figure skating team event results. 

Ultimately, the IOC decided to remove Valieva’s results from the cumulative team score and keep all other scores the same. This led to the US and Japan teams moving to the first and second spots, with the ROC team dropping to third, rather than disqualifying the entire team results and moving Canada to the third spot. So far four appeals to CAS, three from Russia and one from Canada, were filed challenging the ISU’s amended team event standings.  

The handling of Valieva’s case led to many criticisms, primarily related to using a teenage athlete as a scapegoat in a flawed system. Valieva was the only one punished in this case, even though she was 15 years old at the time. Many believe the testing delay was inappropriate and she should have never been in this situation to begin with, while others believe her coaching staff should be at fault. This case has led WADA officials to indicate their desire to update the anti-doping code “before the 2026 Winter Olympics in Italy to give more powers to investigate athlete entourages.” The head of the IOC, Thomas Bach, expressed concerns over the Valieva case and stated that “doping is very rarely done alone with the athletes,” indicating a need to hold athletes’ support teams accountable. 

The World Anti-Doping Code “is the core document that harmonizes anti-doping policies, rules and regulations within sport organizations and among public authorities around the world,” and is updated every six years with the next global review set in late 2025. This review is when anti-doping violation rules may be overhauled in response to the Valieva case, especially to take into account various agencies’ requirements to investigate minor athletes’ support teams. Some changes have already been implemented since the Valieva case. Approximately four months after the 2022 Olympic Games in June 2022, the ISU voted to gradually increase the age limit for senior competitive skaters from 15 to 17. The 17 year age limit will be in effect for the 2026 Winter Olympic Games in Italy. This decision was largely believed to be in response to the Valieva controversy and an effort to better protect minors in the sport. The age limit increase is just the beginning of the overhaul in procedures and safeguards needed to protect athletes in the sport. The legal and procedural decisions by CAS, WADA, and other agencies in the coming years prior to the 2026 Winter Olympic Games are vital for the sport of figure skating to continue in a clean, fair, and legal manner.

The Strippers’ Bill of Rights: a Revolution in Adult Entertainment

By: Karina Paup Byrnes

On March 24, 2024, Washington’s State Governor, Jay Inslee, signed into law the “Strippers’ Bill of Rights” (SB 6105/ HB 2036), which provides adult dancers with increased safety protections in the workplace. Adult entertainers employed at strip clubs across Washington state are now legally entitled to safeguards such as keypad entrances to dressing rooms, panic buttons in private room where employees are alone with customers, mandatory sexual harassment training for all employees, and security guard staffing on site. However, this bill represents more than just a win for workers’ safety and financial security. The legislation importantly recognizes that adult entertainers should be afforded the same rights and protections as any other employee, allowing dancers to more freely and safely participate in the creative expression of their profession.

Strippers Are Workers

The Strippers’ Bill of Rights movement was spearheaded by the dancer-led organization known as Strippers are Workers (“SAW”). SAW “fights to empower the dancers of Washington state so that they can strip safely, positively, and lucratively.” Established in 2018, the organization has been a leader in calling for greater regulation of the adult entertainer industry in Washington. SAW has successfully advocated for reductions in industry practices that are harmful to dancers. Its work has enabled dancers to gain protective measures that are both essential for maintaining a safe work environment and crucial for reducing stigmas and other barriers that adult entertainers face.

The SAW’s work has enabled more financial freedom for dancers, seen best in one critical aspect of the Strippers’ Bill of Rights. Currently, dancers must pay a set club fee for every shift they work, whether or not they make money during the shift. Thus, unpaid fees carry over from previous shifts. After its passage, the bill caps these fees at $150 or 30% of the total amount the employee earned during their shift, whichever is less. Additionally, the legislation bars clubs from carrying over unpaid fees. Impeding clubs from imposing predatory financial constraints over their employees will lessen dancers’ burdens to work with potentially hazardous clients and give them greater financial independence.

Increased Revenue, Safety, and Freedom

A key component of the legislation involved repealing the prohibition of alcohol sales in strip clubs. Prior to the bill’s passage, Washington was the only state that imposed an absolute ban on alcohol sales in strip clubs. This restriction limited the revenue of dancers and clubs and put pressure on dancers to engage with guests, even when such guests arrived at the club highly intoxicated or were known to be violent. The purpose behind allowing strip clubs to apply for alcohol licenses is to prevent abuse of dancers and to enable greater financial mobility for employers and employees. Additionally, with the increased revenue generated through alcohol sales, clubs should be able to afford the safety protections as required by the Act.

The Strippers’ Bill of Rights signals that mandated safety measures in strip clubs are long overdue. Proponents of the legislation are celebrating the reform of adult entertainer establishments not just for the increased physical safety and potential positive financial effects, but also for the validation of dancers as employees who deserve respect and autonomy in the workplace. These protective measures empower dancers and enable them to retain the self-expression that is an important element of their work.On a larger scale, the bill also demonstrates the growing movement towards the decriminalization of sex work. SAW’s campaign manager stated that “there needs to be more of a national push for a more radical and revolutionary way of establishing labor rights, because, you know, it is 2024 and it’s time to do things differently.” As the Washington State Department of Labor and Industries starts drafting and implementing the new rules and guidelines for adult entertainment clubs over the next year, many will be looking at how the work environment for dancers will begin to change for the better. Protecting the rights and interests of dancers participating in sex work has garnered more attention by lawmakers, and advocates hope that other states will follow in Washington’s steps.

Emulation or Piracy for Profit? Nintendo Says No.

By: Kevin Vu

Nintendo, the developer of various beloved video games and consoles, was recently in the news for its lawsuit against, and subsequent settlement with, Tropic Haze, the developers of the Nintendo Switch emulator “Yuzu.” In the initial complaint, Nintendo alleged that “[w]ith Yuzu in hand, nothing stops a user from obtaining and playing unlawful copies of virtually any game made for the Nintendo Switch, all without paying a dime to Nintendo or any of the hundreds of other game developers and publishers making and selling games for the Nintendo Switch. In effect, Yuzu turns general computing devices into tools for massive intellectual property infringement of Nintendo and others’ copyrighted works.” In essence, Nintendo alleged that Tropic Haze “facilitate[d] piracy at a colossal scale.”

Nintendo’s battles against piracy are nothing new. The company has a storied history of filing lawsuits against various forms of piracy – including individuals who sold Nintendo Switch-hacking devices and international cases against Nintendo game copy-holding websites. But some commentators argue that emulation is not piracy – which might explain why Nintendo has yet not filed similar lawsuits against other emulators like “Dolphin” (which emulates the Nintendo Wii). 

Emulation or Piracy?

Emulation, as commonly referred to in this context, means a computer program that “imitates a video game console.” At first blush, it is easy to see why such programs would be an issue for first-party developers like Nintendo. Emulation programs might disincentivize consumers from buying the latest video game console to play their video games for example.  The historic answer to criticisms like that is that emulation falls under fair use. 

For example, in Sony Computer Entertainment v. Connectix Corp., 203 F.3d 596, 609 (9th Cir. 2000), the Ninth Circuit determined that an emulator for Sony’s PlayStation did not infringe on Sony’s copyright because that emulator fell under fair use. Courts typically consider four factors for determining whether fair use applies: (1) the purpose and character of the use, (2) the nature of the copyrighted work, (3) the amount and substantiality of the portion used in relation to the copyrighted work as a whole, and (4) the effect of the use upon the potential market value of the copyrighted work. 17 U.S.C. § 107. Under the Ninth Circuit’s precedence at the time, fair use preserved the public’s access to elements in copyrighted computer codes. Sony Comput. Ent., 203 F.3d at 603. The court determined that the second factor weighed in favor of fair use because Sony’s program was not publicly available such that the defendant’s process of reverse engineering Sony’s program was necessary to replicate the program. Id. at 603-04. As to the first and fourth factors, the court concluded that the defendant’s emulation program was transformative because it “afford[ed] opportunities for game play in new environments” such that “the [emulator was] a legitimate competitor in the market for platforms on which Sony and Sony-licensed games [could] be played.” Id. at 606-07. Accordingly, the court concluded that the emulation of Sony’s PlayStation was protected under fair use. Id. at 609.

That reverse engineering approach was codified by the Digital Millennium Copyright Act (DMCA) as 17 U.S.C. § 1201(f), which generally allows for reverse engineering of a computer program “for the sole purpose of . . . achiev[ing] interoperability of an independently created program[.]” 

In contrast, piracy is understood as “[t]he illegal reproduction and distribution of copyrighted material on the Web.” That definition is distinguishable from the situation in the Sony Computer Entertainment case because there, the emulator was essentially a reverse engineered PlayStation that did not wholly copy Sony’s program. But, as some proponents have argued, emulation naturally leads to piracy because emulators do not have anti-piracy safeguards. The idea behind this is that a video game console, like the Nintendo Switch, will have safeguards that disallow someone from using a pirated copy of a game, but emulators do not have that same protection. Because emulators can run on pirated games, the argument is that emulators support piracy by doing so, resulting in lost profits for the developers of both games and consoles. In contrast, however, some argue that emulation is necessary to preserve the history of video games, along with letting people enjoy games or video game systems that are no longer produced or supported.

Why Yuzu was Targeted.

Many individuals have theorized that Yuzu was targeted because the program emulated a current-generation console in the Nintendo Switch, as opposed to other emulators which are focused on older consoles that are no longer supported. Others have pointed out that Nintendo’s original complaint did not explicitly argue that the Yuzu emulator was illegal, but rather because Yuzu’s developers showed how to break into Nintendo’s game files or even a Nintendo Switch. Additionally, the complaint also noted that Yuzu had a Patreon page (a website that allows people to support creators by donating on a monthly subscription basis) that provided subscribers with early access and unreleased features to the public – in short, that Tropic Haze was profiting from Yuzu. 

Whatever the reason, Nintendo’s actions have already had wide effects on other emulators. For example, Tropic Haze was also developing “Citra,” a 3DS emulator, but under their settlement agreement with Nintendo, Citra has also been discontinued. Another Nintendo console emulator, “DraStic” (for the Nintendo DS), used to be a paid app on Google Play but has since been free to download. 

All of this is a signal that Nintendo, and perhaps other companies, may seek to be more litigious with emulators. Although the DMCA and case law may allow certain forms of emulation, clearly Nintendo is looking at other strategies to fight emulators. For example, when the Dolphin emulator was seeking to be added to the Steam storefront, Nintendo told Steam that Dolphin did not comply with the DMCA because Dolphin used Nintendo’s encryption keys. Dolphin disputed that determination, but Steam refused to allow Dolphin on its storefront until Dolphin and Nintendo could reach an agreement. Currently, Dolphin is still available on the Internet for download and use. Whatever the case, individuals and emulators should be wary about Nintendo’s – and other video game company’s – recent efforts in combating emulation and privacy.

Is Trade Secret Law the New Patent Law?

Exploring Alternate Avenues to Patent Protection of AI-Designed Pharmaceuticals

By: Anushka Parihar

Artificial intelligence (AI) continues to revolutionize industries worldwide. A rapidly evolving application of AI is now emerging in the pharmaceutical industry, resulting in AI-designed pharmaceuticals. 

Many businesses use AI and machine learning algorithms as a tool to sift through large databases of data to identify potential drug targets and design molecules that interact with those targets. AI is also utilized to promote the efficiency of clinical trials by predicting the efficacy of untested drugs. Consequently, AI is an essential tool in creating therapeutics for a wide range of human conditions.

The emergence of AI as a key tool for drug discovery sparks questions about how to afford intellectual property protections to AI-designed drugs. 

Patentability of AI-Designed Pharmaceuticals

Patent law has traditionally been the main source of IP protection in the pharmaceutical industry. Patent protection is important to sustained progress in this field, where competition and profit is key. The research and development process for creating drugs is lengthy, complex, and expensive. Without the 20-year monopoly afforded by patent protection, pharmaceutical companies may not have the ability to fund their research, thereby losing the economic incentive that drives drug innovation.

The United State Patent and Trademark Office (USPTO) released guidelines for AI patentability in February 2024. These guidelines largely follow the Federal Circuit’s holding in Thaler v. Vidal that only natural persons can be inventors, and therefore, AI cannot be named as an inventor in a patent application. Although this does not preclude AI-assisted inventions from patentability, it does pose a significant barrier in cases where a human did not provide a significant contribution to the invention. Courts are directed to evaluate the significance of human contribution on an individual basis but simply owning or overseeing AI is not enough to contribute to the invention. 

Even though some actors may still be able to assert that their AI-designed pharmaceuticals are patentable, the lack of case law makes it difficult to predict how the USPTO and the courts will rule on issues regarding patent protection of AI-designed drugs. Due to the recent implementation of the patent guidelines, it may take three to five years to get concrete insight into what constitutes significant human involvement in AI-assisted inventions. 

This leaves a large problem for companies and inventors who depend on patent protection to recoup their sizable investments into drug discovery. As such, alternate intellectual property protections must be considered.

Trade Secret Law as a Possible Solution 

The Defend Trade Secrets Act defines a trade secret as information that derives independent economic value from not being generally known or readily ascertainable. Trade secrets are protected under both federal and state law and are enforced domestically and globally. There is no formal registration or validation process. Most importantly, there are currently no requirements for human creators and inventors in trade secret law. 

These characteristics make trade secret protection an excellent avenue for protecting AI-designed drugs. Since information generated by AI is not generally known or readily ascertainable, it is novel information gathered by the AI tool using set inputs. In fact, AI’s capacity to find patterns and create formulas that are not easily understandable to people underscores its immense potential in the pharmaceutical sector. 

To be a valid trade secret, the creator must have taken reasonable measures to keep sensitive information confidential. As long as businesses and collaborators are protecting the various inputs, outputs, and algorithms used by AI tools, they should be able to claim trade secret protection. Trade secret law also provides for remedies in the event of misappropriation, which occurs when a trade secret is acquired by improper means or disclosed without consent. 

Of course, no solution comes without its own issues. Replacing patent protection with trade secret protection isn’t a complete answer. Trade secret law does not afford protection when information is acquired through reverse engineering, independent development, or instances where the trade secret becomes general industry knowledge. Due to this restriction, companies may be unable to claim trade secret misappropriation when others decipher and subsequently replicate AI-assisted processes that led to the creation of a novel drug. 

Additionally, pharmaceutical companies often rely on their patent portfolios to build credibility and attract ongoing investments. These portfolios are considered intangible assets and can increase a company’s valuation in the market. While trade secrets absolutely contribute to a company’s intellectual property portfolio, they tend to be considered invisible components, as any disclosure outside of permissible limits is considered misappropriation and leads to the loss of a trade secret. In contrast, patent portfolios, which include patents that are necessarily published and fully disclosed, are easily valued and understood. As a result, trade secret law may not be a good replacement to patent law in terms of building a portfolio to further a company’s financial goals. This consequence is of particular concern due to the significant investment in research and development that is vital to the pharmaceutical industry. 

While replacing patents with trade secrets may not be the most viable long-term solution, it seems to be one of the only ways for businesses to gain intellectual property protections for AI-assisted inventions. In light of the new AI-related patentability requirements which may preclude patent protection, drug companies may want to start turning to trade secret law to protect their novel pharmaceuticals.